Human interleukin DA-1a (HILDA)/LIF,G-CSF, IL-1 beta, IL-6, and TNF alpha production during acute kidney graft rejection episodes.
Blancho
G
G
Service de Néphrologie-Immunologie Clinique CHR, Nantes, France.
Moreau
J F
JF
Chabannes
D
D
Chatenoud
L
L
Soulillou
J P
JP
D000208:Acute Disease; D006084:Graft Rejection / Q000188:drug therapy / Q000276:immunology*; D016179:Granulocyte Colony-Stimulating Factor / Q000032:analysis / Q000096:biosynthesis*; D006131:Growth Inhibitors / Q000032:analysis / Q000096:biosynthesis*; D006801:Humans; D007375:Interleukin-1 / Q000032:analysis / Q000096:biosynthesis*; D015850:Interleukin-6 / Q000032:analysis / Q000096:biosynthesis*; D016030:Kidney Transplantation / Q000276:immunology*; D053605:Leukemia Inhibitory Factor; D008222:Lymphokines / Q000032:analysis / Q000096:biosynthesis*; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis / Q000096:biosynthesis*
D006131:Growth Inhibitors; D007375:Interleukin-1; D015850:Interleukin-6; C507837:LIF protein, human; D053605:Leukemia Inhibitory Factor; D008222:Lymphokines; D014409:Tumor Necrosis Factor-alpha; D016179:Granulocyte Colony-Stimulating Factor